RACHEL TOMLIN: Open Payments
NPI 1770981227 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 16 payments from 9 companies in 2025. Trend: 2023 $819 · 2024 $309 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $90 |
| Philips North America LLC | 2 | $66 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $45 |
| Boston Scientific Corporation | 1 | $41 |
| Novo Nordisk Inc | 1 | $29 |
| Abbott Laboratories | 1 | $29 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $16 |
Products named: LEQVIO, Extended Holter, LifeVest, CDS broad portfolio offering, CAMZYOS, Ozempic, MERLIN@HOME, NEXLETOL.
Industry payments across TX — which companies pay providers there.
